⌘K

Login Start Free

Home/Filings/4/0001171000-17-000045

4//SEC Filing

Nexvet Biopharma plc 4

Accession 0001171000-17-000045

CIK 0001618561operating

View on SEC.gov Company Profile

Filed

Jul 4, 8:00 PM ET

Accepted

Jul 5, 12:28 PM ET

Size

11.1 KB

Accession

0001171000-17-000045

Insider Transaction Report

Form 4

Period: 2017-06-30

Nexvet Biopharma plcNVET

Director

Transactions

Exercise/Conversion
Ordinary Shares
2017-06-30$0.13/sh+500$63→ 12,420 total
Exercise/Conversion
Ordinary Shares
2017-07-01$0.13/sh+3,600$450→ 16,020 total
Exercise/Conversion
Restricted Share Units
2017-07-01−3,600→ 0 total
Exercise: $0.13From: 2017-07-01Exp: 2021-07-01→ Ordinary Shares (3,600 underlying)
Exercise/Conversion
Restricted Share Units
2017-06-30−500→ 0 total
Exercise: $0.13From: 2017-06-30Exp: 2019-07-01→ Ordinary Shares (500 underlying)

Holdings

Ordinary Shares
(indirect: By Trust)
1,500

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

Nexvet Biopharma plc

CIK 0001618561

Entity typeoperating

IncorporatedIreland

Related Parties

1

filerCIK 0001618561

Filing Metadata

Form type: 4
Filed: Jul 4, 8:00 PM ET
Accepted: Jul 5, 12:28 PM ET
Size: 11.1 KB

View on SEC.gov